STAT3 and urogenital neoplasm: It has been reported that STAT3 may bind to the MALAT1 promoter and transcriptionally stimulate its expression in a model of prostate cancer identifying the IL-8/STAT3/MALAT1 axis as a key regulator during prostate tumorigenesis (37).